Genmab Announces AbbVie Receives Positive CHMP Opinion for Epcoritamab (TEPKINLY®) for the Treatment of Adults with Relapsed/Re
21/7 10:30
Company Announcement The positive CHMP opinion is supported by results from the EPCORE™ NHL-1 p hase 1/2 trial evaluating the preliminary efficacy and safety of epcoritamab in patients with non-Hodgkin’s lymphoma (NHL), including diffuse large B-cell lymphoma (DLBCL) DLBCL is an aggressive subtype...